Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Market Cap	87.62B -5.9%
Revenue (ttm)	75.76B +9.0%
Net Income	8.31B +56.3%
EPS	84.85 +56.3%
Shares Out	97.90M
PE Ratio	10.55
Forward PE	7.61
Dividend	40.00 (4.47%)
Ex-Dividend Date	Apr 22, 2026

Volume	30,922
Open	889.98
Previous Close	n/a
Day's Range	885.00 - 899.00
52-Week Range	821.00 - 1,304.00
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; and import and marketing of nutritional products. It also imports and markets diagnostic equipment, m...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,380
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2025, PSX:ABOT's revenue was 75.40 billion, an increase of 10.59% compared to the previous year's 68.18 billion. Earnings were 7.97 billion, an increase of 52.20%.